Julian Robertson Alpine Immune Sciences, Inc. Transaction History

Tiger Management L.L.C.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$6.71 - $9.52 $924,154 - $1.31 Million	-137,728 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$4.09 - $7.19 $102,250 - $179,750	-25,000 Reduced 15.36%	137,728 $945,000
Q3 2017 Nov 14, 2017	BUY	$8.0 - $11.6 $1.3 Million - $1.89 Million	162,728	162,728 $1.89 Million

56.2K

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

Get notified when there are updates to the investment portfolio of Tiger Management L.L.C., based on Form 13F filings with the SEC.

Stay updated on Tiger Management L.L.C. and Julian Robertson with notifications on news.